TOURS, France, Dec. 10, 2025 (GLOBE NEWSWIRE) — Igyxos Biotherapeutics, a biotechnology company dedicated to developing innovative monoclonal antibodies for infertility treatment, today announced the successful completion of its Phase 1 clinical trial evaluation of IGX12. The recent Multiple Ascending Dose (MAD) Phase 1 trial of IGX12 was a randomised, placebo-controlled study in 14 healthy […]

CathVision, a medical technology company dedicated to improving clinical outcomes in cardiac electrophysiology through high-fidelity signal acquisition and intelligent software, today announced two major milestones: the appointment of Eric Thepaut as independent Chairman of the Board, and the commercial release of Version 3.5 of the ECGenius® System. https://mma.prnewswire.com/media/2842487/Eric_Thepaut.jpg Eric Thepaut Appointed Independent Chairman of the

Berlin Heals Holding AG (Zug, Switzerland) is pleased to announce the appointment of Rob ten Hoedt as the new Chairman of the Board of Directors. https://mma.prnewswire.com/media/2622179/Berlin_Heals_Logo.jpg “We are thrilled to welcome someone of Rob ten Hoedt's caliber to the Board,” said Marko Bagaric, Co-founder and Member of the Board of Directors. “His global impact on

Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced the launch of a new health-focused kombucha-inspired product and a strategic collaboration with Shaanxi Qingshengyuan Health Industry Co., Ltd. (“Qingshengyuan”), a leading distributor of functional health products in China focusing

Rakovina Therapeutics Announces Upcoming Webinar with Variational AI From Handshake to Breakthrough: How Rakovina & Variational AI Are Cracking the Code on CNS-Penetrant Cancer Therapies GlobeNewswire December 10, 2025 VANCOUVER, British Columbia, Dec. 10, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer

Igyxos Biotherapeutics Announces Positive Results from Phase 1 Trial of IGX12, its First-in-Class Monoclonal Antibody for the Treatment of Male and Female Infertility GlobeNewswire December 10, 2025 TOURS, France, Dec. 10, 2025 (GLOBE NEWSWIRE) — Igyxos Biotherapeutics, a biotechnology company dedicated to developing innovative monoclonal antibodies for infertility treatment, today announced the successful completion of

Korean wellness beverage brandZAKSIMLAB is accelerating its presence in the functional drink market with the launch of three new fruit-infused kombucha flavors and a refreshed Lemon Apple Cider Vinegar drink. Under the slogan “Deliciously Healthy,” ZAKSIMLAB has built its identity around naturally fermented, clean-label functional drinks. Its signature kombucha line-which features probiotics from natural fermentation

JOILTECH, a manufacturer specializing in ID-related accessories, has unveiled new products that significantly enhance user safety and convenience: a slide-type employee ID case and a detachable safety-pin lanyard. The new lineup aims to improve access control environments across corporations and public institutions while meeting growing market demand for durability, safety, and customization. JOILTECH develops, designs,

DUBAI, United Arab Emirates, Dec. 10, 2025 (GLOBE NEWSWIRE) — A fast-growing project in the lending sector of the DeFi crypto market is now entering one of the most important stages of its early development. Mutuum Finance (MUTM) has released a new update confirming strong progress across its roadmap while allocation levels move toward full

Mutuum Finance (MUTM) Reports 96% Phase Allocation as Halborn Security Audits Q4 V1 Protocol GlobeNewswire December 10, 2025 DUBAI, United Arab Emirates, Dec. 10, 2025 (GLOBE NEWSWIRE) — A fast-growing project in the lending sector of the DeFi crypto market is now entering one of the most important stages of its early development. Mutuum Finance